Related Experiment Video
Updated: Jul 6, 2026

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
Published on: March 24, 2023
[Non-pharmacological treatment of musculoskeletal pain]
1Klinika za reumatologiju, fizikalnu medicinu i rehabilitaciju, Klinicka bolnica "Sestre milosrdnice", Vinogradska 29, 10000 Zagreb.
Abstract:
Non-pharmacological treatment is important in management of musculoskeletal pain. Therapeutic modalities such as superficial heat or cold agents, therapeutic ultrasound, laser and/or electric currents have been used extensively for various musculoskeletal diseases and conditions. They have many advantages over other pain-modifying interventions. However, relatively few high-quality research studies have been performed to elucidate mechanisms underlying their analgesic properties and there are insufficient controlled efficacy findings supporting the use of various physical agents in the management of pain conditions. The cornerstones of non-pharmacological management of chronic musculoskeletal pain are education, exercise and cognitive-behavioural therapy, ideally in combination through the multidisciplinary treatments programs based on biopsychosocial model of pain. From the available evidence it can not be concluded whether an indivudual patient with chronic pain should be referred to cognitive-behavioural treatment programs or active conservative treatment. There is a need for further studies to clarify the type and manner of non-pharmacological treatments, their intensity, duration and progression according to patient-specific outcomes.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
